PSMA-negative prostate cancer and the continued value of choline-PET/CT

被引:16
|
作者
Alberts, Ian [1 ]
Sachpekidis, Christos [1 ]
Fech, Viktor [1 ]
Rominger, Axel [1 ]
Afshar-Oromieh, Ali [1 ]
机构
[1] Univ Bern, Univ Hosp Bern, Inselspital, Dept Nucl Med, Bern, Switzerland
来源
NUKLEARMEDIZIN-NUCLEAR MEDICINE | 2020年 / 59卷 / 01期
关键词
D O I
10.1055/a-1044-1855
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:33 / 34
页数:2
相关论文
共 50 条
  • [31] Molecular imaging for prostate cancer: Performance analysis of 68Ga-PSMA PET/CT versus choline PET/CT
    Michaud, L.
    Touijer, K. A.
    ACTAS UROLOGICAS ESPANOLAS, 2017, 41 (05): : 292 - 299
  • [32] Choline PET/CT in recurrent prostate cancer
    Detti, Beatrice
    Carnevale, Maria Grazia
    Lucidi, Sara
    Burchini, Luca
    Caini, Saverio
    Orsatti, Carolina
    Bertini, Niccolo
    Roghi, Manuele
    di Cataldo, Vanessa
    Fondelli, Simona
    Ingrosso, Gianluca
    Francolini, Giulio
    Scartoni, Daniele
    Sardaro, Angela
    Pisani, Antonio
    Scoccianti, Silvia
    Aristei, Cynthia
    Livi, Lorenzo
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [33] PET-CT at choline in prostate cancer
    Zouhair, A.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2011, 35 (08): : 445 - 445
  • [34] CD13 as a Potential Membrane Marker in PSMA-Negative Prostate Cancer: A Complementary or Superior Alternative to PSMA
    Tang, Y.
    Xiao, L.
    Yang, J.
    Hou, J.
    Hong, J.
    Rominger, A.
    Shi, K.
    Hu, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S195 - S195
  • [35] Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer
    Bernhard Scher
    Michael Seitz
    Wolfram Albinger
    Reinhold Tiling
    Michael Scherr
    Hans-Christoph Becker
    Michael Souvatzogluou
    Franz-Josef Gildehaus
    Hans-Jürgen Wester
    Stefan Dresel
    European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34 : 45 - 53
  • [36] Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer
    Seitz, M
    Gratzke, C
    Schlenker, B
    Reich, O
    Stief, CG
    Scher, B
    JOURNAL OF UROLOGY, 2006, 175 (04): : 483 - 484
  • [37] Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer
    Scher, Bernhard
    Seitz, Michael
    Albinger, Wolfram
    Tiling, Reinhold
    Scherr, Michael
    Becker, Hans-Christoph
    Souvatzogluou, Michael
    Gildehaus, Franz-Josef
    Wester, Hans-Juergen
    Dresel, Stefan
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (01) : 45 - 53
  • [38] Clinical value of negative68Ga-PSMA PET/CT in the management of biochemical recurrent prostate cancer patients
    Celli, M.
    De Giorgi, U.
    Caroli, P.
    Di Lorio, V
    Fantini, L.
    Rossetti, V
    Foca, F.
    Nicolini, S.
    Giganti, M.
    Paganelli, G.
    Matteucci, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (01) : 87 - 94
  • [39] Clinical value of negative 68Ga-PSMA PET/CT in the management of biochemical recurrent prostate cancer patients
    M Celli
    U De Giorgi
    P Caroli
    V Di Iorio
    L Fantini
    V Rossetti
    F Foca
    S Nicolini
    M Giganti
    G Paganelli
    F Matteucci
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 87 - 94
  • [40] PSMA PET/CT Detected Prostate Cancer Metastasis in a Patient with Negative mpMRI and Prostate Gland Biopsy
    Vetrone, L.
    Cuzzani, G.
    Mei, R.
    Zanoni, L.
    Bertaccini, A.
    Bianchi, L.
    Castellucci, P.
    Gaudiano, C.
    Cappelli, A.
    Giunchi, F.
    Fanti, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S14 - S15